Acadia Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Acadia Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Acadia Pharmaceuticals Inc Strategy Report
- Understand Acadia Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Acadia Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
10 Jan 2022 | Acadia Pharma Enters into Licensing Agreement with Stoke Therapeutics | Licensing Agreement |
Acadia Pharmaceuticals Inc
|
Stoke Therapeutics Inc
|
01 Aug 2021 | Acadia Pharmaceuticals Inc Enters Phase II/III Clinical Trial Agreement with Precision For Medicine Inc for trofinetide (GDCT0429058) | Contract Service Agreement |
Acadia Pharmaceuticals Inc
|
Precision For Medicine Inc
|
16 Mar 2021 | Acadia Pharma Enters into Licensing Agreement with Adamed | Licensing Agreement |
Acadia Pharmaceuticals Inc
|
Adamed Pharma SA
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer